Eventful days of regulation and legislation in the world of pharma and innovation

There have been some eventful days recently in terms of important pharmaceutical regulations and legislation:

• Community pharma strategy to which we dedicated a post on LinkedIn
• Proposal for a Data Governance Regulation. Re-use of certain public sector data, including health data, which is key to boosting biomedical research.
• RD on observational studies. Simplifying administrative procedures, more efficient assessment of the quality and suitability of each study and updating guarantees on transparency and access to information from these studies.
• Reference price order
• COVID-19 vaccination strategy in Spain.
• Public consultation on the Science, Technology and Innovation Bill. The consultation period is now open.

This post is also available in: Spanish